Nasdaq:US$15.93 (+0.51) | HKEX:HK$25.75 (+0.55) | AIM:£2.35 (+0.09)
搜索结果
上一篇文章   |   下一篇文章
公告及新闻稿, 其他业务 | 2014-04-17

Chi-Med and Sinopharm complete regulatory approval for the establishment of new China drug distribution and marketing Joint Venture